Switzerland · 
What does HBM Partners invest in?
HBM Partners invests most often at Series B and Series C (46% of the rounds on record), in sectors such as Drugs, Psychedelics and Protein.
HBM Partners highlights
- 01
14 rounds on record
- 02
Mostly Series B and Series C: 46% of its rounds
- 03
Sole investor in 1 rounds, median $13M
- 04
2 exits from the portfolio
What they do
Welcome to HBM Partners, a leading Asset Manager in HealthcareFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $5.0M – $50M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- DrugsPsychedelicsProtein
- Based in
- Zug, Switzerland
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first14 appearances
- 2015
2 rounds
- Jul
- May
- 2014
3 rounds
- Dec
- Nov
- Jul
- 2013
3 rounds
- Feb
- Feb
- Jan
- 2008
1 round
- Jul
- 2005
1 round
- Oct
- 2004
3 rounds
- Aug
- Mar
- Jan
- 2002
1 round
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
Gemin X PharmaceuticalsBought by Cephalon$525MMar 2011
Aspreva Pharmaceuticals CorpBought by Galenica Ltd.UndisclosedOct 2007
An exit counts when it came after the firm's first round in the company. From historical deal records.